Monday, March 30, 2020
CJ CheilJedang Voluntarily Recalls Noodle Product in U.S. due to Peanut Allergy Concern
CJ’s Pre-empted Measure
CJ CheilJedang Voluntarily Recalls Noodle Product in U.S. due to Peanut Allergy Concern
  • By 비지니스코리아
  • February 20, 2020, 18:54
Share articles

CJ Foods America Holdings recalled Teriyaki Noodle Bowl.
CJ Foods America Holdings recalled Teriyaki Noodle Bowl.

CJ CheilJedang voluntarily recalls its Teriyaki Noodle Bowl sold in the United States. This is because the U.S. Food and Drug Administration (FDA) recommended a recall of the product as peanut ingredients were detected in the product although the product’s ingredient information table does not have it.

CJ Foods America Holdings, a US subsidiary of CJ CheilJedang, recalled Teriyaki Noodle Bowl as it was found to have peanut ingredients marked on the product package on Feb. 14 (local time), said sources in the FDA and the food industry on Feb. 18.

CJ Food America reported it to the U.S. FDA immediately after detecting the ingredient and the FDA officially announced the recall on its homepage. The recall target was Teriyaki Noodle Bowl of “Annie Chun” Brand, and the product’s expiration date is Dec. 25 of 2020. CJ Food America made the recall on discovering that pad Thai noodles with peanut were used in the product without an allergic warning notice.

CJ Food America is disposing of products that are not yet distributed, and is contacting customers to dispose of already sold products. Consumers who purchase the product will be refunded in full if they contact their places of purchase or the company.

CJ Food America launched the recall of the product because it was concerned about the safety of consumers with a peanut allergy. If you have nut allergies, such as peanut allergies, eating products that contain allergens can generate serious negative side effects and even threaten the lives of people with such allergies.

"CJ Foods places a top priority on product quality and safety," said Mike Smith, a CJ Foods spokesperson. “We immediately informed our consumers of the fact by closely cooperating with the FDA.”